Literature DB >> 24360987

Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses.

José M Porcel1, Aureli Esquerda2, Manuel Vives3, Silvia Bielsa4.   

Abstract

OBJECTIVE: To investigate the etiology of pleural effusions (PE) in adults and the accuracy of pleural fluid (PF) cytology and cultures in malignant and infectious PE, respectively. PATIENTS AND METHODS: Retrospective analysis of all consecutive patients with PE undergoing diagnostic thoracentesis during the last 19 years in a university hospital.
RESULTS: The leading causes of PE among the 3,077 patients were: cancer (27%), heart failure (21%), pneumonia (19%), tuberculosis (9%), abdominal surgery (4%), pericardial diseases (4%) and cirrhosis (3%). Tuberculosis was the most common etiology in patients <34 years of age (52%), whereas heart failure predominated in octogenarians (45%). The most common primary tumors in malignant PE were lung (37%) and breast (16%). The overall accuracy of PF cytology was 59%, although it was significantly lower in mesotheliomas (27%) and squamous cell lung cancer (25%). In infectious PE, only 30% of cultures yielded positive results, a percentage which increased two-fold (66%) in purulent fluids (empyemas). Viridans streptococci were the most commonly isolated pathogens (25.5%). The sensitivity of solid media cultures of PF for Mycobacterium tuberculosis was low (18.5%).
CONCLUSIONS: Three-quarters of patients with PE in whom a diagnostic thoracentesis was indicated had cancer, heart failure, pneumonia or tuberculosis. PF cytology and cultures give false negative results in a significant number of cases.
Copyright © 2013 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Cancer; Cáncer; Derrame pleural; Heart failure; Insuficiencia cardiaca; Neumonía; Pleural effusion; Pneumonia; Thoracentesis; Toracocentesis; Tuberculosis

Mesh:

Year:  2013        PMID: 24360987     DOI: 10.1016/j.arbres.2013.11.007

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  60 in total

1.  Pleural Effusions in Diffuse Large B-Cell Lymphoma: Clinical and Prognostic Significance.

Authors:  José M Porcel; Irene Cuadrat; Tomás García-Cerecedo; Marina Pardina; Silvia Bielsa
Journal:  Lung       Date:  2018-11-30       Impact factor: 2.584

2.  Predominance of Th1 Immune Response in Pleural Effusion of Patients with Tuberculosis among Other Exudative Etiologies.

Authors:  Vinícius da Cunha Lisboa; Marcelo Ribeiro-Alves; Raquel da Silva Corrêa; Isabelle Ramos Lopes; Thiago Thomaz Mafort; Ana Paula Santos; Thaís Porto Amadeu; Rogério Rufino; Luciana Silva Rodrigues
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

3.  Significance of congestive heart failure as a cause of pleural effusion: Pilot data from a large multidisciplinary teaching hospital.

Authors:  Piotr Korczyński; Katarzyna Górska; Damian Konopka; Dżamila Al-Haj; Krzysztof J Filipiak; Rafał Krenke
Journal:  Cardiol J       Date:  2018-11-08       Impact factor: 2.737

Review 4.  Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis.

Authors:  Panwen Tian; Yongchun Shen; Chun Wan; Ting Yang; Jing An; Qun Yi; Lei Chen; Tao Wang; Ye Wang; Fuqiang Wen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 5.  Interpreting pleural fluid results .

Authors:  Rachel M Mercer; John P Corcoran; Jose M Porcel; Najib M Rahman; Ioannis Psallidas
Journal:  Clin Med (Lond)       Date:  2019-05       Impact factor: 2.659

6.  Development and Validation of the COMPLES Score for Differentiating Between Tuberculous Effusions with Low Pleural pH or Glucose and Complicated Parapneumonic Effusions.

Authors:  Luis Corral-Gudino; Alberto García-Zamalloa; Cristina Prada-González; Silvia Bielsa; Duckens Alexis; Jorge Taboada-Gómez; Pilar R Dos-Santos-Gallego; María A Alonso-Fernández; Jose M Porcel
Journal:  Lung       Date:  2016-07-11       Impact factor: 2.584

7.  Sarcopenia in patients with malignant pleural effusion: impact on symptoms, health status, and response to hospitalization.

Authors:  Janet Rodríguez-Torres; Laura López-López; Irene Cabrera-Martos; Gerald Valenza-Demet; Lawrence P Cahalin; Marie Carmen Valenza
Journal:  Support Care Cancer       Date:  2019-04-03       Impact factor: 3.603

Review 8.  Advances in the diagnosis of tuberculous pleuritis.

Authors:  José M Porcel
Journal:  Ann Transl Med       Date:  2016-08

9.  Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.

Authors:  José M Porcel; Cristina Solé; Antonieta Salud; Silvia Bielsa
Journal:  Lung       Date:  2017-09-12       Impact factor: 2.584

Review 10.  Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions?

Authors:  Giles Dixon; Duneesha de Fonseka; Nick Maskell
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.